selected publications
-
Optimization of T-cell Receptor-Modified T Cells for Cancer Therapy.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 14 -
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 15 -
T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance.
Immunological reviews.
2019
Review
GET IT
Times cited: 128 -
TOX is a critical regulator of tumour-specific T cell differentiation.
Nature.
2019
Academic Article
GET IT
Times cited: 495 -
T cell stemness and dysfunction in tumors are triggered by a common mechanism.
Science (New York, N.Y.).
2019
Academic Article
GET IT
Times cited: 258 -
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.
The Journal of clinical investigation.
2019
Academic Article
GET IT
Times cited: 88 -
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 140 -
Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.
Journal of vascular and interventional radiology : JVIR.
2018
Academic Article
GET IT
Times cited: 12 -
Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy.
Trends in molecular medicine.
2018
Review
GET IT
Times cited: 49